Market Research Blog – Page 1207 – New Product Development

FMI Study States Global Currency Counting Machines Market Revenue Anticipated to Surpass USD 373.4 Million by 2033, Driving 4.9% CAGR

According to the FMI projections, the currency counting machines market is expected to experience substantial growth, reaching an estimated value of USD 231.4 million in 2023 and projecting a robust increase to USD 373.4 million by 2033. The industry is estimated to undergo a CAGR of 4.9% during forecast period.

This notable surge is primarily attributed to the rising incidents of counterfeit currency circulation, although potential hindrances such as the increasing prevalence of card-based transactions may impact this upward trajectory. The market dynamics are significantly influenced by the growing adoption of multi-currency forex cards, representing a noteworthy departure from traditional travel currency cards that are limited to a single currency.

Importantly, industry manufacturers are actively pursuing innovative techniques to enhance counterfeit detection capabilities. By leveraging advanced optical inspection and image processing technologies, they aim to deliver sophisticated and intelligent cash sorting solutions capable of reliably identifying fraudulent currencies.

The increased emphasis on the importance of counterfeit detection and security measures is driving a heightened demand for sophisticated currency counting devices. This surge in demand is particularly evident in sectors such as casinos, supermarkets, and hotels, where the efficient and accurate processing of cash is integral to daily operations. Manufacturers are responding to this demand by developing cutting-edge solutions to meet the evolving needs of these industries.

Key Takeaways:

By 2033, the currency counting machines market in the United Kingdom is likely to expand, with a CAGR of 2%.
In 2023, the United States is expected to develop the currency counting machines business with a share of 4%.
The currency counting machines market grew considerably to USD 9,220.5 million in 2022.
The currency counting machines sector developed at a CAGR of 7% between 2018 and 2022.
By 2033, China’s currency counting machines market is projected to develop with a CAGR of 7%.
By 2033, India’s currency counting machines industry is projected to expand with a CAGR of 3%.
Japan’s currency counting machines industry is likely to grow significantly, with a 0% share in 2023.
Australia’s currency counting machines are expected to develop with a share of 1% in 2023.
Germany’s currency counting machines business is expected to grow, with a share of 6% in 2023.
In 2023, based on the type, the loose note segment is expected to dominate the market, with a share of 44%.
In 2023, a BFSI segment is expected to dominate the market, with a share of 36%, based on application.

Competitors’ Successful Techniques:

Competitive pricing emerged as a critical factor within the market landscape, leading to the acquisition of substantial customer bases by businesses offering high-quality cash-counting machines at competitive price points. Several enterprises directed their efforts towards the development of specialized cash-counting equipment tailored to meet distinct industrial requirements. This strategic approach enabled them to cater to niche markets effectively and gain a competitive edge within the industry.

Top 10 Key Players of Currency Counting Machines Market:

Web Sec Systems
Cannon Electronic Systems
Prompt Automation
Giesecke & Devrient GmbH
Cummins Allison Corp.
De La Rue plc
Bcash
Electronics Co.
Glory Global Solutions Limited
GRGBanking

Recent Development:

A cash counting machine with a capacity of 200 notes, an intelligent currency counter cum detector, and a loose note counting machine are all available from the firm Maxsell. In.
Through its subsidiaries, Glory Global Solutions (International) Ltd. and Glory Global Solutions (Holdings) Ltd., announced the purchase of Grupo Sortek S.A. de C.V. in May 2019. In Mexico, Sortek offers services for sorting cash.

Key Segments Profiled in the Currency Counting Machines Market Survey:

By Type:

Loose Note
Bundle Note
Desktop Model

By Range:

Basic Note Counter
Hi-Speed Heavy Duty Cash Counting
Intelligent Counting cum Counterfeit Detection Machines

By Application:

BFSI
Business Houses
Hospitals
Schools & Colleges
Airports
Jewelers
Retail Outlets & Showroom
Hotels & Restaurants

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Access Report Details for More In-Depth Information!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI Analysis Affirms Global Construction Equipment Maintenance and Repair Market Revenue to Cross USD 33.96 Billion Milestone by 2033

The global construction equipment maintenance and repair market is anticipated to grow at a CAGR of 4.1% in 2023 and reach an estimated value of USD 22.72 billion. In 2033, the construction equipment maintenance and repair industry is expected to be worth USD 33.96 billion.

As businesses are anticipated to place a greater emphasis on research and development operations for maintaining and repairing vehicles, the construction equipment maintenance and repair industry is predicted to rise steadily.

It would considerably improve the lifespan and operational state of many devices. Due to a few new emerging technologies in the automotive sector, there will be some changes to how vehicles are repaired and serviced.

Dynamics of the Global Construction Equipment Repair and Maintenance Market:

Over the upcoming years, it is anticipated that the repair and maintenance services for both heavy and light construction equipment may continue to make up the same percentage of the construction equipment maintenance and repair market. Wheel loaders are anticipated to experience a significant growth rate among serious construction equipment repair and maintenance services.

Mini excavators are among the light constriction equipment predicted to continue a steady development rate. Repair and maintenance services for construction equipment are anticipated to expand significantly in Europe, largely thanks to increasing German residential construction industry demand.

Construction equipment maintenance and repair business are strengthening their efforts in developing nations like India and Latin America. The primary market-boosting initiatives are projects for new roads, improved infrastructure, new airports, irrigation systems, and urban infrastructure.

The market expansion for construction equipment maintenance and repair can be restrained by the ineffective availability of financing choices, poor uptime of construction equipment repair and maintenance services, a lack of government backing, and a sluggishly penetrated leasing or rental sector. One of the most prevalent industry trends is that OEMs are increasingly focusing more on repairing and maintaining construction equipment, which may increase construction equipment maintenance and repair market competition.

Key Takeaways:

The United States might increase its market share for construction equipment maintenance and repair by 19.50% % between 2023 and 2033.
Between 2023 and 2033, Germany may hold 6.9% of the construction equipment maintenance and repair industry.
Japan’s share of the construction equipment maintenance and repair industry could reach 7.8% between 2023 and 2033.
Australia to hold a 3.5% share of the construction equipment maintenance and repair business from 2023 to 2033.
During the forecast period, Chinese construction equipment maintenance and repair business to expand at a CAGR of 4.2%.
From 2023 to 2033, the United Kingdom construction equipment maintenance and repair industry to register at a 3.9% CAGR.
Through 2033, the Indian construction equipment maintenance and repair market to record a CAGR of 4%.
The consumables segment to acquire a substantial market share of 67.4% in the components category between 2023 and 2033.
The aftermarket segment to hold a significant market share of 47.3% in the sales channel category between 2023 and 2033.

Competitive Landscape

With so many companies striving for market share, the rivalry in the construction equipment maintenance and repair may be fierce. Competition in the market may come from construction equipment maintenance and repair manufacturers, specialized repair and maintenance service providers, equipment rental businesses, and even original equipment manufacturers (OEMs).

The key to remaining competitive in construction equipment maintenance and repair industry is adapting to new technology, providing complete services, and forming solid bonds with customers.

Top Key Players in Construction Equipment Repair and Maintenance Market:

Chevron Lubricants
ExxonMobil
RelaDyne
Atlas Copco
Castrol
Taylor Oil Company
Valvoline
Uslube
Duralene
Polygraph

Key Segments Covered:

By Component:

Consumable
Grease
Engine Oil
Radiator Coolant
Brake Oil
Hydraulic Fluids
Transmission Fluid
Gear Oil
Parts
Excavator Bucket Teeth
Hydraulic Cylinder
Hydraulic Pumps
Track Chain
Belt
Batteries
Fuel Injector
Engine Starter
Air Filters

By Sales Channel:

OEM
OES
After Market

By Vehicle:

Dozer
Loaders
Graders
Scrapers
Backhoe Loaders
Compactors

By Service Provider:

Authorized Service Center
Third-Party Service Center
Independent Service Center

By Service Type:

Repair and Maintenance
Service Only

By Region:

North America
Latin America
Europe
East Asia
South Asia Pacific
The Middle East and Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Over-the-Counter Pain Medication Market to Experience Steady Growth, Projected to Reach New Heights by 2034

The over-the-counter pain medication market is set for substantial growth in the coming decade. According to the latest projections, the market is expected to achieve a significant valuation USD 35,090.10 million by 2034, marking a notable increase from its expected value USD 23,705.60 million in 2024. The over-the-counter analgesics sector is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.0% between 2024 and 2034.

This anticipated growth reflects a rising demand for accessible pain relief solutions and an increasing preference for OTC medications among consumers. The market’s upward trajectory is driven by factors such as the growing prevalence of chronic pain conditions, a heightened focus on self-medication, and continuous advancements in OTC pain relief products.

Leading players in the OTC pain medication market are collaborating with generic drug-makers to capitalize on the trend of consumer inclination towards generic versions of branded OTC pain medications, finds FMI.

Key Companies Profiled

Pfirzer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Sanofi S.A.
GlaxoSmithKline plc.
Bristo-Meyers Squibb and Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Merck & o.
Cardinal Health Inc.

The FMI study features valuable and actionable insights obtained through thorough research on OTC pain medication market. Some of the insights mentioned in the study are,

Growing geriatric population and prevalence of chronic pain-related disorders among the elderly population is bolstering sales of OTC pain medications.
Over 20% of the adult population of the world is already suffering from pain-related disorders and new cased of pain-related problems are reported by over 10% of the global population, which is increasing significantly every years. This is providing an impetus to growth of the OTC pain medication market.
Increasing awareness about the side effects of pain killers, such as stomach ulcers and gastrointestinal problems, may hamper the OTC pain medication market growth.
Developed countries will dominate the OTC pain medications market with more than half the revenue share of the market. However, developing countries in Southeast Asia will witness fastest growth in the OTC pain medication market with rapidly developing pharmaceuticals and healthcare sector in the region.

Acetaminophen Drugs Hold Majority Share in OTC Pain Medication Market

The FMI study thoroughly assesses growth of the OTC pain medication market based on various drug classes, such as Nonsteroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and local anesthetics.

The study finds that acetaminophens are among the most commonly purchased OTC pain medication, and this drug class holds 45% share in the revenues of OTC pain medication market. As acetaminophen is considered as a safer pain medication than other pain relievers, its demand will continue to remain high in the upcoming years, opines the FMI study.

The Consumer Healthcare Products Association (CHPA), an American trade association, recently published a study on the misuse of acetaminophen-based OTC combination products. The study found that a 28 percent decline was recorded in therapeutic misuse exposures involving acetaminophen-containing OTC combination products.

The incidents of acetaminophen misuse decreased from 8,753 to 6,278 between 2007 and 2016, which is a substantial evidence for the safety and effectiveness of acetaminophen-containing OTC pain medications.

Thereby, the FMI study opines that the acetaminophen drugs will maintain a maximum share of over US$ 8.7 billion in the OTC pain medication market through 2019, and the trend will continue to persist in the coming future.

Governments take Initiatives to Spread Awareness about Safe Use of OTC Pain Medications

Despite the increasing reliance on OTC pain medications, a large consumer group is still skeptical about their effectiveness and positive impacts on health. In order to help consumers to avoid incorrect use of OTC pain medications, many governing bodies including FDA have developed guidelines and tips for patients for choosing appropriate OTC pain medications.

Consumers are becoming conscious about the drug fact labeling (DFL) requirements and other regulations vis-à-vis OTC pain medications, which is influencing major dynamics of the OTC pain medication market, projects the FMI study.

The study provides a futuristic overview of the OTC pain medication market with important information about growth prospects of the market during the forecast period 2022-2028. The study predicts that the OTC pain medication market will witness healthy growth at a healthy 4.1% value CAGR to reach US$ 27.7 Bn by the end of the assessment period.

A Old Full Report Analysis Click Here

Key Segments:

Over-the-Counter Pain Medication Market by Drug Class:

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Local Anaesthetics
Acetaminophen

Over-the-Counter Pain Medication Market by Route of Administration:

Oral
Topical
Others

Over-the-Counter Pain Medication Market by Dosage Form:

Tablets
Capsules
Creams
Gels
Others

Over-the-Mounter Pain Medication Market by Distribution Channel:

Hospital Pharmacies
Drug Stores
Retail Stores
through e-Commerce
Others

Over-the-Counter Pain Medication Market by Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Endometriosis Treatment Market Poised for Steady Growth at 3% CAGR, Reaching USD 4 Billion by 2030

The Endometriosis Treatment Market is charting a course for stable expansion, fueled by growing awareness and a rise in diagnosed cases. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to exhibit a Compound Annual Growth Rate (CAGR) of approximately 3% from 2019 to 2030. This consistent growth trajectory is expected to propel the market valuation to surpass USD 4 billion by the end of the forecast period, reflecting a significant increase from US$2.8 billion in 2018.

The steadfast growth of this industry is propelled by the escalating prevalence of endometriosis, a condition affecting millions of women worldwide. As the demand for advanced treatment options continues to surge, industry leaders are taking the helm, focusing on pioneering therapeutic advancements and strategic product launches.

Key Takeaways of Endometriosis Treatment Market Study

Based on the drug, oral contraceptives contributed maximum value share to the global endometriosis treatment Industry in 2018, owing to a high preference for them as a first-line therapy for patients without contraindications, and efficacy in preventing the recurrence of pelvic pain and endometriosis lesions.
High treatment efficacy and acceptance with low risk are expected to result in a notable share of hormonal therapy in the treatment type.
The hospital pharmacies and retail pharmacies segments, collectively, hold above 60% of the value share of the endometriosis treatment industry, owing to the high patient pool in hospitals and visiting retail pharmacies.
Europe captured a notable revenue share of 37% in 2018 and is expected to be the most lucrative region in the global endometriosis treatment market during the forecast period.
Increasing government expenditure for the high growth of the medical industry in emerging economies in the Asian region is expected to drive the growth of the endometriosis treatment industry across this region.

Multiple New Indications – Imperative Strategy for Endometriosis Treatment Market Players

Increasing the introduction of endometriosis drugs with multiple new indications is a major factor responsible for intense competition among market players. Several companies are focusing on launching new endometriosis treatment options to increase their product sales and expand their market share. For example, in July 2018, AbbVie Inc. introduced a new innovative product – Orilissa(elagolix) tablets, a gonadotropin-releasing hormone (GnRH) receptor antagonist for the management of moderate to severe pain associated with endometriosis, in the U.S. market.

What else is in the report?

Future Market Insights (FMI) offers a unique perspective and actionable insights on the endometriosis treatment market in its latest study, presenting a historical demand assessment of 2014-2018 and projections for the period of 2019-2030, based on the drug (oral contraceptives, progestins, NSAIDs, GnRH analogs, LNR-IUDs, and others), treatment type (hormonal therapy and pain management), and distribution channel (hospital pharmacies, retail pharmacies, drugstores, and e-Commerce), across seven key regions of the world.

A Old Full Report Analysis Click Here

Endometriosis Treatment Market Segmentation

The global endometriosis treatment industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug:

Oral Contraceptives
Progestins
NSAIDs
GnRH Analogues
LNR-IUDs
Others

Treatment Type:

Hormonal Therapy
Pain Management

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drugstores
e-Commerce

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vein Finder Market Set for Steady Growth, Projected to Reach USD 52.4 Million by 2034 at a 3.4% of CAGR

The global vein finder market is poised for consistent growth, with projections indicating an increase from USD 37.6 million in 2024 to USD 52.4 million by 2034. The market is expected to advance at a compound annual growth rate (CAGR) of 3.4% over the forecast period.

In 2023, the global vein finder industry was valued at $37.5 million, and it is anticipated to experience a robust year-on-year growth rate of 7.0% in 2024. This strong performance underscores the increasing demand for vein finders, driven by advancements in medical technology and an expanding healthcare sector.

The total revenue from vein finders is projected to grow by 1.4 times by 2034, highlighting the market’s potential for significant expansion. This growth is attributed to the rising adoption of vein finders in clinical settings, improved technology, and a greater focus on enhancing patient care through innovative medical devices.

“Innovations like these are expected to increase adoption of advanced Vein Finders in hospitals and healthcare establishments, leading to significant revenue growth of the Global Vein Finder Industry. Our analysis of the performance of the Vein Finder market reveals an absolute $ opportunity of US$ 3.0 Million between 2018 and 2019 and the global market is estimated to register a stellar growth rate of 10.9% in the coming decade.” Practice Head – Healthcare & Medical Devices, Future Market Insights

Global Vein Finder Industry Structure Overview: Regional Focus to Bolster Global Market Growth

An overview of the market structure of the Global Vein Finder Industry reveals a strong regional presence of top market companies as well as local players. Leading companies operating in the Global Vein Finder Industry are leveraging acquisitions as a primary strategy to facilitate regional market expansion. Future Market Insights analysis also observes a strong focus by Vein Finder companies on R&D for new product development and expansion of the existing product line in key regional growth markets.

“Implementation of inorganic growth strategies is seen as the way forward to penetrate key growth markets across certain developing regions. Companies in the Vein Finder market with diversified product offerings are collaborating with local regional players to introduce low-cost Vein Finder products to cement their presence across top regional markets.”

In 2017, the leading three companies in the Global Vein Finder Industry held a revenue share of about 56% while the remaining players contributed about 44% market share. New product development is a key strategy adopted by players in the Global Vein Finder Industry to increase their brand value. Rising difficulties associated with peripheral venous access, venepuncture is one of the primary factors boosting the growth of the Global Vein Finder Industry, and key players are capitalizing on the growth drivers to increase their market share.

Future Market Insights predicts lucrative revenue growth in the various regional markets of Europe and Asia Pacific Excluding Japan. Europe will likely remain the top market for sales of Vein Finder devices owing to the increasing adoption of Vein Finder across hospitals and clinics to locate veins for drawing blood samples, IV insertions, and other vascular procedures.

Portable Vein Finder to Garner Maximum End User Demand; Infrared Technology to Register Fastest Growth in Revenue

Portable Vein Finders are likely to be the most preferred product type in the Global Vein Finder Industry, registering impressive demand as well as sales growth in the coming decade. The convenience and ease of use offered by portable Vein Finders is the primary factor boosting adoption across hospitals, clinics, and other healthcare institutions. The Global Vein Finder Industry is fuelled by advanced technology with infrared technology being the most adopted in Vein Finders. Among the various end users of Vein Finders, hospitals are likely to exhibit the highest demand in the next 10 years, also contributing to maximum revenues in the global Vein Finder market.

Vein Finder Market Competitive Landscape

The market for Vein Finders is fragmented by nature, with only a few players present. These players are part of several strategic alliances. The product launch and acquisition speed up the manufacturer’s strategy to capitalize on market share and gain a sizable market share.

Furthermore, the corporations are focusing on the launch of new items to boost their product portfolio in the Asia Pacific area to expand their clientele and capture the largest market share in emerging economies.

Vein Finder Market Key Players

AccuVein Inc.
Christie Medical Holdings
Koninklijke Philips N.V
Osang Healthcare Co. Ltd
Teleflex Inc. (Acq. VueTek Scientific, LLC.)
TransLite, LLC
ZD Medical
Vivolight
Venoscope LLC
Shenzhen Bestman Instruments Co., Ltd

A Old Full Report Analysis Click Here

Vein Finder Market by Category

By Product:

Portable
Benchtop

By Technology:

Ultraviolet
Infrared
Ultrasound

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers and Path Labs
Veterinary Clinics
Home Care Settings
Blood Banks

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Sustained Release Excipients Market Set for Steady Growth at 7.5% CAGR, Reaching USD 1,198.69 Million by 2032

The Sustained Release Excipients Market is experiencing a growth spurt, fueled by the increasing demand for long-acting medications. A recent industry analysis reveals a promising outlook, with the market valued at a substantial US$1,198.69 million in 2022. Looking ahead, the market is projected to climb at a robust Compound Annual Growth Rate (CAGR) of 7.5%, reaching an estimated US$1.8 billion by 2032.

The sustained release excipients market has historically been characterized by regional manufacturers vying for market share, primarily through competitive pricing strategies. This fragmentation has affected the profitability of companies operating within the sector. However, a shift is occurring due to an enhanced understanding of sustained release excipients and the limitations related to test specificity and sensitivity for locally produced sustained release excipients.

Companies like BASF Corporation, Ashland Global Holdings Inc., and Dow Chemical Company generate more than 42.8% of the market’s revenue for sustained release excipients globally. The businesses involved in this industry are collaborating with local distributors to increase the penetration of their products in the sustained release excipients market.

Research identifies the largest revenue shareholding categories in the sustained release excipients marketplace based on product type, end-user, and route of administration.

Polymer is currently the largest product type category worth US$ 300 Million, whereas gelatin represents the most opportunistic one.
While the oral route of administration remains highly sought after, injectable is presumed to gradually take over.
Biopharmaceutical companies and CMOs pose fierce competition to pharmaceutical companies – the dominant end-user of sustained-release excipients.

“The top five players leading the competition in the global sustained release excipients landscape account for a collective revenue share of over 50%, whereas several relatively small companies represent the rest. A majority of competitors have a limited offering portfolio and significantly depend on product differentiation for an edge in niche treatment areas,” explains a senior research analyst. “Product innovation and market expansion have been the top developmental strategies of companies so far, which are now complemented with strategic partnerships,” the analyst adds further.

Multi-level Partnerships – The Key to Delivering Top-Notch Excipient Formulations

FMI underlines the critical role of strategic collaborations – between formulators of sustained release excipients and stakeholders across the value chain – in shaping the growth of brands as well as the entire sustained release excipients ecosystem.

While partnerships are expected to prominently focus on spotting the key challenges facing manufacturers, continued education about functionality, variability, and consistency of sustained release excipients is also an important objective. Drug product manufacturers working in tandem with formulators of sustained-release excipients are helping companies deliver best-in-class solutions addressing the most prominent pull factors associated with sustained-release excipients.

To best grasp real-time market needs, sustained-release excipient formulators are most likely to strengthen interaction with end-user customers. This move offers a dual advantage as a developmental strategy – by helping manufacturers precisely understand and address the challenges facing pharmaceutical markets and stimulating the development of new excipient formulations that tap into evolving needs.

A recent deal (2017) involving the combination of The Dow Chemical Company-DuPont-FMC (Health & Nutrition) has been a classic example of a collaborative operation, involving channel partners as well as customers.

Additional Questions Answered

Some of the additional questions addressed in this report on the Global Sustained Release Excipients Industry-

What is the revenue potential of the sustained release excipients market across regions of North America and Europe?
Who are the key competitors and what are their portfolios in the sustained release excipients market?
What are the major challenges influencing the growth of the sustained-release excipients market?
How intervention from regulatory authority is shaping the sustained release excipients market growth?

Sustained Release Excipients Market Competitive Landscape:

The competition section of the sustained release excipients market features profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, marketing approach, and company dashboards. Examples of some of the key players featured in this report include FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company, Roquette Freres S.A. Colorcon Inc., and Croda International Inc.

Sustained Release Excipients Market Segmentation:

The report offers a comprehensive taxonomy of the sustained release excipients market based on product type, end-user, route of administration route, and region. The sustained-release excipients are sold for various types of test samples, such as blood, skin, etc. These sustained-release excipients are used by pharmaceutical companies, biopharmaceutical companies, and neutraceutical companies, and for various types of sustained-release excipients, such as food allergies, drug allergies, latex allergies, and other types of allergies.

End-use segments in the sustained release excipients market which are a part of this sustained release excipients Industry report include pharmaceutical companies, biopharmaceutical companies, and other end users, such as nutraceutical manufacturers and contract manufacturing organizations. The sustained release excipients market has been analyzed across regions of North America, Latin America, Europe, CIS & Russia, Asia Pacific, and MEA.

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cell Line Development Market Poised for Robust Growth, Projected to Reach USD 4,674.8 Million by 2033 at a 4.1% of CAGR

The global cell line development market is set to experience significant expansion, with a projected compound annual growth rate (CAGR) of 4.1% over the forecast period. According to the latest market analysis, total sales of cell line products are anticipated to rise from USD 3,124.4 million in 2023 to USD 4,674.8 million by 2033.

The cell line development market, valued at USD 3,007.3 million in 2022, is expected to demonstrate a year-over-year growth of 3.9% in 2023. This upward trend is driven by the increasing demand for cell-based therapies, advancements in biotechnology, and the growing application of cell lines in research and development.

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

Cell Line Development Market Key Segments :

Reagent and Media
Equipment
Accessories and consumables

By Source Type:

Mammalian cell line
Non-mammalian cell line

By End User:

Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Biotechnology Companies

By Cell Lines:

Recombinant cell lines
Hybridomas
Continuous cell lines
Primary cell lines

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Extremity Tissue Expanders Market is projected to grow at a CAGR of 6.3% to reach USD 1.84 Billion by 2028

The pursuit of aesthetic perfection is driving a new wave of medical innovation. The Extremity Tissue Expander Market is experiencing significant growth, reflecting the increasing demand for body augmentation procedures. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to reach a value of USD 1.84 billion by 2028. This represents a steady Compound Annual Growth Rate (CAGR) of 6.3% from 2018 to 2028.

Global Extremity Tissue Expanders Industry: Overview & Analysis

It is observed that reconstructive procedures have undergone a tremendous shift from conventional invasive procedures to minimally invasive surgeries. Advancements and development of long-lasting improved extremity tissue expanders are expected to be the key factors driving the growth of the industry. Presently, advancements in technology have led to the development of extremity tissue expanders, with an expansion of potential shape types. There are several limitations of traditional and conventional medical surgeries, such as long recovery time, more chances of infection, and highly expensive procedures. These limitations have resulted in a shift to minimally invasive procedures. Extremity tissue expanders today have become extremely versatile in nature with patients’ like-mindedness in going forward with the procedure. This transformation has led to a positive impact on the Global Extremity Tissue Expanders Industry growth. The number of surgeries with extremity tissue expanders is expected to increase with other prevalent factors supporting the rise of the Global Extremity Tissue Expanders Industry in terms of adoption.

The availability of alternative treatment options for reconstructive surgeries may hamper the growth of the Global Extremity Tissue Expanders Industry. To leverage the presence of a large patient pool, various medical device companies involved in the extremity tissue expanders market and new entrants are developing treatment options that can improve the care for reconstructive procedures. Moreover, the European Medical Agency has very stringent regulatory approval standards due to which most of the products fail to reach the extremity tissue expanders market. Several extremity tissue expander manufacturers are focusing on the development of new products. However, due to stringent regulations and lengthy approval processes, most of the products do not reach the extremity tissue expanders market, which hampers the growth of the extremity tissue expanders market to a certain extent, and alternative treatment options are being adopted. The market is segregated into definite terms but the lack of procedures and products in developing countries affects the overall Global Extremity Tissue Expanders Industry growth and rise in alternative support care.

The breast reconstruction segment by product type is expected to dominate the Global Extremity Tissue Expanders Industry. The breast reconstruction segment is expected to gain a market value of US$ 943.4 Mn in the Global Extremity Tissue Expanders Industry in 2017. This is due availability of favorable reimbursement scenarios for the treatment of breast cancer. The breast reconstruction segment of extremity tissue expanders by product type is also expected to grow at a faster rate and it is anticipated to grow at a CAGR of 6.3% throughout 2018-2028 owing to a rise in several breast reconstruction procedures throughout the globe. Scalp reconstruction and oral and maxillofacial reconstruction segment of extremity tissue expanders market by product type is expected to be less lucrative in terms of value.

By shape type, an anatomical segment of the Global Extremity Tissue Expanders Industry is expected to gain maximum market share and is estimated to reach a market value of US$ 682.9 Mn in 2028. This is due variety of products with anatomical shapes available in the extremity tissue expanders market. Among all end users, the hospital segment is expected to be the most lucrative segment for the Global Extremity Tissue Expanders Industry though a maximum number of breast reconstruction surgeries are performed in hospitals.

North America is expected to dominate the Global Extremity Tissue Expanders Industry in terms of value by region. North American region for extremity tissue expanders is estimated to gain a market value of US$ 233.7 Mn in 2018, though North America holds the maximum number of key manufacturers for extremity tissue expanders. After North America, the extremity tissue expanders market is then followed by Europe and APEJ. By region, APEJ is anticipated to show faster growth than other regions in the Global Extremity Tissue Expanders Industry, and the APEJ region is projected to grow at a CAGR of 7.7% over the forecast period.

Extremity Tissue Expanders Market: Companies

FMI’s report tracks some of the key companies operating in the Global Extremity Tissue Expanders Industry, such as GC Aesthetics Plc., Koken Co. Ltd., Allergan Plc., Mentor Worldwide LLC, Laboratories Arion, Wright Medical Group N.V. Groupe Sebbin SAS, Sientra Inc., Guangzhou Wanhe Plastic Materials Co. Ltd., and Guangzhou Wanhe Plastic Materials Co., Ltd.

A Old Full Report Analysis Click Here

Extremity Tissue Expanders Market Segmentation

The report offers a comprehensive taxonomy of the Global Extremity Tissue Expanders Industry based on product type, shape type, end user, and region. Based on product type extremity tissue expanders market is segmented as Breast Reconstruction, Scalp Reconstruction, and Oral and Maxillofacial Reconstruction. Based on shape type Global Extremity Tissue Expanders Industry is segmented as round, rectangular, crescent, anatomical, and others.

The Global Extremity Tissue Expanders Industry report also includes the end-user segment which covers hospitals, ambulatory surgical centers, and cosmetics clinics. The extremity tissue expanders market has been analyzed across regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and MEA.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ultraviolet Analyzers Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

The market for UV analyzers is predicted to grow at a rapid pace, reaching $2.4 billion by 2033, up from $1.3 billion in 2023. During the forecast period, a strong compound annual growth rate (CAGR) of 6.5% is expected to drive this significant increase. The worldwide UV analyzer market is expected to be worth US$1.2 billion in 2022, paving the way for a phenomenal 10 years of growth.

Ultraviolet Analyzer Market: Drivers and Restraints

Physical disinfection using ultraviolet analyzer is driving the ultraviolet analyzer market

The ultraviolet analyzer provides rapid, sufficient inactivation of microorganism through the physical process through a physical process. Viruses and bacteria are exposed to the germicidal wavelength of Ultraviolet light, to make them incapable of reproducing and infecting. Ultraviolet light can destroy chemical contaminants such as industrial solvents, pharmaceutical, and pesticides through UV-oxidation.

Demand for ultraviolet analyzer technology is increasing in chemical industry

UV absorption spectroscopy is used to determine the impurities in organic molecules. The contaminants are detected by measuring the absorbance at a specific wavelength. The ultraviolet analyzer determines the compounds that absorb UV radiation. The ultraviolet analyzer identifies the presence of a functional group in a compound. It is also used to study the kinetics of the reaction by passing UV radiation through the reaction cell and observing absorbance changes.

Restraints:

Lack of skilled workforce is restricting the growth of ultraviolet analyzer market

Demand of ultraviolet analyzer in different sectors is increasing, as the demand is increasing there are new developments and technological advancement in the market. The worker have to adapt themselves to new technologies which is difficult task for some employees. Due to this the worker are not ready to adapt themselves to new changes, which results in restriction in growth of the market.

Ultraviolet Analyzer Market: Competition Landscape

Some prominent players in ultraviolet analyzer market are First Light Technologies, Atlantic Ultraviolet Corporation, Calgon Carbon Corporation, Trojan Technologies, Xylem Inc., Severn Trent Plc, Evoqua Water Technologies, Aquionics, and Atlantium Technologies among others.

Ultraviolet Analyzer Market: Regional Outlook

Geographically, North America and Europe region holds prominent market share in ultraviolet analyzer market, owing to the presence of UV disinfection companies in the countries of these regions. Furthermore, Asia Pacific region is expected to grow in the ultraviolet analyzer market as the countries in this region are using UV sterilization in water and wastewater treatment. Middle East and Africa are creating lucrative opportunities for the ultraviolet analyzer market.

The ultraviolet analyzer market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The market report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on

Ultraviolet Analyzer Market Segments
Ultraviolet Analyzer Market Dynamics
Ultraviolet Analyzer Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Technology
Value Chain of the Market
Market Drivers and Restraints

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Rest of LATAM)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Rest of Western Europe)
Eastern Europe (Russia, Poland, Rest of Eastern Europe)
Japan
Asia Pacific Excluding Japan (China, India, South Korea, ASEAN, Australia & New Zealand, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Northern Africa, South Africa, Rest of MEA)

Ultraviolet Analyzer Market: Segmentation

Ultraviolet Analyzer Market segmentation on basis of application:

Water treatment
Air treatment
Food & Beverage Disinfection
Others

Ultraviolet Analyzer Market segmentation on basis of vertical:

Oil & gas
Healthcare
Food & Beverages
Chemical
Agriculture
Others

Request a Sample of this Report

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Low-Code Embedded Analytics Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

According to Future Market Insights’ detailed study, the Low-Code Embedded Analytics Market has grown significantly over the years. Sales in the industry reached an astounding US$ 8.3 billion in 2018, and the market is expected to rise at a rate of 7.4% each year through 2022.

The future prospects for this dynamic business are equally excellent, with sales expected to reach $12.4 billion by 2023. Looking ahead to 2023-2033, the worldwide market is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.6%, reaching a market size of $37.2 billion by the end of 2033.

Request a Sample of this Report

Key Takeaways

The Low-Code Embedded Analytics Market achieved remarkable sales of US$ 8.3 billion in 2018, with a 7.4% Y-o-Y growth in 2022.
Anticipated revenues for 2023 are US$ 12.4 billion, with a projected CAGR of 11.6% during 2023-2033, ultimately reaching a market size of US$ 37.2 billion by 2033.
Low-code embedded analytics empower industries by providing data-driven insights, enhancing decision-making, and operational efficiency.
The market is driven by the demand for real-time analytics, user-friendly data visualization tools, scalability, and flexibility.
North America and Europe lead in market adoption, with Asia-Pacific experiencing rapid growth.
Data security concerns, the need for skilled professionals, and competition from traditional providers present challenges to market growth.

Drivers and Opportunities

Low-code embedded analytics have emerged as a game-changing solution across various end-use industries. The technology is a catalyst for harnessing data effectively, enabling enhanced decision-making, operational efficiency, and improved outcomes. As businesses increasingly recognize the importance of data-driven insights, the low-code embedded analytics market has experienced significant growth.

The rising demand for real-time data analytics and visualization tools has been a major driver of this market. With low-code solutions, companies can rapidly develop and deploy analytics, gaining a competitive edge. Furthermore, the scalability and flexibility of low-code embedded analytics cater to the evolving needs of businesses, making them an attractive choice.

Opportunities abound as businesses worldwide seek to optimize their operations. Low-code embedded analytics offer a versatile and user-friendly approach to creating data-driven applications, which appeals to organizations looking to streamline their processes. With a focus on delivering actionable insights, these solutions empower decision-makers to make informed choices, leading to better business outcomes.

Competitive Landscape – Regional Trends

The Low-Code Embedded Analytics Market is characterized by intense competition and regional variations. The market players are constantly innovating to maintain their competitive positions and expand their market share. Regional trends show variations in the adoption and implementation of low-code embedded analytics.

North America, as a mature market, continues to dominate the low-code embedded analytics landscape. The region’s early adoption of technology and a robust IT infrastructure have driven market growth. Europe follows closely, with increasing investments in data-driven solutions. Meanwhile, the Asia-Pacific region is witnessing rapid growth, owing to the expanding digital landscape and a surge in small and medium-sized enterprises.

Restraints

While the low-code embedded analytics market is on a growth trajectory, it’s not without challenges. Data security concerns and the need for skilled professionals to implement these solutions can act as restraints. Data breaches and privacy issues are critical concerns for businesses and organizations, slowing down the adoption rate.

Additionally, the market faces competition from traditional analytics providers, who are also enhancing their offerings. These factors, coupled with a lack of awareness in some regions, could hinder the market’s full potential.

Region-wise Insights – Category-wise Insights

Region-wise, North America and Europe are expected to maintain their dominance in the low-code embedded analytics market. North America’s early adoption and Europe’s increasing investments make them key regions. Asia-Pacific, Latin America, and the Middle East and Africa are poised for significant growth, as emerging economies embrace these analytics solutions.

Category-wise, cloud-based low-code embedded analytics solutions are gaining traction due to their scalability and cost-effectiveness. On the other hand, on-premises solutions remain relevant for businesses with stringent security and compliance requirements.

Segmentation Analysis of the Low-Code Embedded Analytics Market

By Application:

CRM Analytics
Supply Chain Analytics
Marketing Analytics
Financial Analytics
HR Analytics

By Deployment:

Cloud-Based Platforms
On-Premises Platforms

By Enterprise Size:

Small Offices (1-9 employees)
Small Enterprises (10-99 employees)
Medium-sized Enterprise (100-499 employees)
Large Enterprises (500-999 employees)
Very Large Enterprises (1,000+ employees)

By Industry:

IT & Telecom
Retail
Banking Financial Services & Insurance
Manufacturing
Healthcare
Others

By Region:

North America
Latin America
Europe
East Asia
South Asia Pacific
Middle East & Africa

About Future Market Insights (FMI)

Contact Us: